NBN. A. Bileva

N. A. Bileva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


N. A. Bileva has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern etiotropic therapy of chronic viral hepatitis B

    by E. B. Bun'KOva, N. A. Bileva, A. E. Bilev, M. I. Sinel'NIkov

    Chronic viral hepatitis B (CHB) is a significant global health problem. The biological characteristics of the hepatitis B virus, which causes this disease, significantly impede the achievement of complete virus elimination in most patients. In this regard, the rational choice of drugs and antiviral therapy regimens is crucial for increasing life expectancy and improving the quality of life in patients with CHB. The purpose of this literature review is to identify current approaches and trends in etiotropic therapy for CHB.Materials and methods. The review uses data published in domestic and foreign scientific journals, clinical guidelines, regulatory documents, and Internet resources.Results. Currently, the most effective means of etiotropic therapy for CHB are interferons (standard interferon alpha, pegylated interferons alpha-2a and alpha-2b), as well as first-line nucleoside/nucleotide analogs (entecavir, tenofovir) and second-line analogs (lamivudine, telbivudine, adefovir). The choice of a specific drug is determined by the patient's clinical condition, preferences, availability, and cost of treatment. Despite certain limitations of current etiotropic therapies for CHB, their use can significantly increase patients' life expectancy and improve their quality of life.

  • Open Access

    The feasibility of pathogenetic therapy for chronic viral hepatitis C in adult HIV-infected patients

    by E. B. Bun'KOva, N. A. Bileva, M. I. Sinel'NIkov, A. E. Bilev

    In the third decade of the XXI century, HIV infection and viral hepatitis C remain urgent problems of modern medicine. Only in the Russian Federation in 2023, more than 1.6 million HIV-infected people and about 2 million patients with chronic viral hepatitis C are registered. Patients with a combined course of these diseases are of particular concern. However, insufficient coverage of etiotropic therapy for patients with chronic viral hepatitis C due to its high cost leaves pathogenetic therapy as the only available method of treatment for many of them. Material and Methods. Clinical data of patients hospitalized in the day hospital of the state budgetary health care institution "Samara Regional Clinical Center for AIDS Prevention and Control" were used. Physical, virological, immunological, biochemical and general clinical methods, elastometry of liver tissue were used for examination of hospitalized patients. Statistical processing of the results was performed using the application program "Statgrarhics Plus for Windows". Pathogenetic therapy was carried out in a two-week course in accordance with the "Recommendations for the diagnosis and treatment of adult patients with hepatitis C" (2013) and included (along with protective regime and therapeutic nutrition) the use of detoxification and metabolic therapy. Antiretroviral therapy with 3–4 drugs was carried out in 68% of the patients. Results. It was shown that the prescribed course of pathogenetic therapy of chronic viral hepatitis C did not have the expected effectiveness in the majority of patients referred for treatment according to the dynamics of changes in the values of "liver tests", despite the fact that the "right subcostal syndrome" was eliminated in 75.7% of persons with stage 3 and 66.7% with stages 4A and 4B of HIV infection. Statistical studies of the relationship (linear, rank and canonical) did not reveal its presence between the results of the conducted treatment and the complex of initial clinical and clinicallaboratory data obtained during hospitalization of the examined persons. Discussion. The presence of cytolysis syndrome and "right subcostal syndrome" is not a valid criterion for referral to a two-week course of pathogenetic therapy of chronic viral hepatitis C in order to obtain a positive result in the majority of patients with stages 3, 4A and 4B of HIV infection. Other baseline data (virologic and immunologic indices, degree of liver tissue fibrosis, indices of general and biochemical blood analysis) had no reliable correlation with the results of treatment, which did not allow their use for predicting the effectiveness of the prescribed treatment. Antiretroviral therapy was not associated with the results of pathogenetic therapy of chronic viral hepatitis C according to the indicators of cytolysis syndrome and "right subcostal syndrome", despite the fact that most of the prescribed drugs had a hepatotoxic effect.

  • Open Access

    Characteristics of the manifestations of the epidemic process of actual natural focal infections in the Samara region

    by L. V. Chupakhina, T. V. Vandysheva, A. E. Bilev, N. A. Bileva

    Features of the landscape and geographical conditions of the Samara region, the rich world of flora and fauna create favorable conditions for the existence of natural foci of infectious and parasitic diseases. The high population density, the presence of megacities (Samara, Togliatti), the passion of the inhabitants of the region for country recreation, together with developed agriculture, determine a high risk of infection of people with pathogens of natural focal infections.Objectives: to analyze the manifestations of the epidemic and epizootic processes of natural focal infections in the Samara region for its zoning according to the degree of danger of infection of the population with actual zoonoses.Methods. We used information on the incidence of the population (form No. 2 "Information on infectious and parasitic diseases") for the period from 2019 to 2021, data from an immunological examination of residents of municipalities using enzyme immunoassay, results of examination of environmental objects in natural foci (indication of genomes and antigens of viruses and bacteria) in vertebrates and their pellets (litter), arthropods using polymerase chain reaction and enzyme immunoassay. Cluster analysis was performed using the Statgraphics plus for Windows application program for a personal computer.Results. Territories with high, moderate and low risk of infection of the population of the Samara region with hemorrhagic fever with renal syndrome, viral tick-borne encephalitis, tularemia, leptospirosis, Q fever and West Nile fever were identified. It is shown that the most relevant zoonosis is hemorrhagic fever with renal syndrome.Discussion. Compiled cartographic mapping of the administrative formations of the Samara region with different risks of infection and disease of people with natural focal infections is relevant for planning preventive measures.


  • Open Access

    Russian vaccines against COVID-19: their characteristics, efficacy and safety

    by A. E. Bilev, A. M. Sokurova, N. A. Bileva, M. A. Kachkovskii, I. P. Vvedenskaya

    The review presents data on the types of vaccines designed to prevent the development of a new coronavirus infection (COVID-19). The procedure for inclusion in the register of funds for use in emergency situations is considered. National regulatory authorities may decide to use vaccines before they are approved by the World Health Organization (WHO) due to the very lengthy registration process. The vaccines approved for use in the Russian Federation, their features, studied efficacy and safety data are listed. Data on the minimum frequency of serious adverse reactions arising from the use of vaccines against COVID-19, which are not comparable with the high frequency of deaths from this disease, are presented. The reasons for the need to develop their own vaccines are listed: the need to quickly vaccinate a huge number of the population during a pandemic, even before WHO registers in the register of funds for use in emergency situations, delays in the receipt of vaccines from countries where they are produced, the potential threat of leakage of pathogenic viruses and bacteria from biological laboratories, ensuring the economic security of the country during pandemics. Conclusions. There are a sufficient number of safe and effective vaccines against COVID-19 in the Russian Federation, developed using various technologies. In view of the ongoing pandemic of a new coronavirus infection, the use of vaccines is of great preventive importance for building individual and collective immunity. The successful development of domestic vaccines in the Russian Federation is important from the point of view of the epidemiological and economic security of the country.